Copyright Reports & Markets. All rights reserved.

Global Huntingtons Disease Therapeutics Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Huntingtons Disease Therapeutics Market Overview

      • 1.1 Product Overview and Scope of Huntingtons Disease Therapeutics
      • 1.2 Huntingtons Disease Therapeutics Segment by Type
        • 1.2.1 Global Huntingtons Disease Therapeutics Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Antidopaminergics
        • 1.2.3 Anticonvulsants
        • 1.2.4 Antipsychotics
        • 1.2.5 Antidepressants
      • 1.3 Huntingtons Disease Therapeutics Segment by Application
        • 1.3.1 Huntingtons Disease Therapeutics Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hosptial
        • 1.3.3 Clinic
        • 1.3.4 Research
      • 1.4 Global Huntingtons Disease Therapeutics Market by Region
        • 1.4.1 Global Huntingtons Disease Therapeutics Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Huntingtons Disease Therapeutics Market Size
        • 1.5.1 Global Huntingtons Disease Therapeutics Revenue (2014-2025)
        • 1.5.2 Global Huntingtons Disease Therapeutics Production (2014-2025)

      2 Global Huntingtons Disease Therapeutics Market Competition by Manufacturers

      • 2.1 Global Huntingtons Disease Therapeutics Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Huntingtons Disease Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Huntingtons Disease Therapeutics Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Huntingtons Disease Therapeutics Production Sites, Area Served, Product Types
      • 2.5 Huntingtons Disease Therapeutics Market Competitive Situation and Trends
        • 2.5.1 Huntingtons Disease Therapeutics Market Concentration Rate
        • 2.5.2 Huntingtons Disease Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Huntingtons Disease Therapeutics Production Market Share by Regions

      • 3.1 Global Huntingtons Disease Therapeutics Production Market Share by Regions
      • 3.2 Global Huntingtons Disease Therapeutics Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Huntingtons Disease Therapeutics Production
        • 3.4.1 North America Huntingtons Disease Therapeutics Production Growth Rate (2014-2019)
        • 3.4.2 North America Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Huntingtons Disease Therapeutics Production
        • 3.5.1 Europe Huntingtons Disease Therapeutics Production Growth Rate (2014-2019)
        • 3.5.2 Europe Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Huntingtons Disease Therapeutics Production (2014-2019)
        • 3.6.1 China Huntingtons Disease Therapeutics Production Growth Rate (2014-2019)
        • 3.6.2 China Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Huntingtons Disease Therapeutics Production (2014-2019)
        • 3.7.1 Japan Huntingtons Disease Therapeutics Production Growth Rate (2014-2019)
        • 3.7.2 Japan Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Huntingtons Disease Therapeutics Consumption by Regions

      • 4.1 Global Huntingtons Disease Therapeutics Consumption by Regions
      • 4.2 North America Huntingtons Disease Therapeutics Consumption (2014-2019)
      • 4.3 Europe Huntingtons Disease Therapeutics Consumption (2014-2019)
      • 4.4 China Huntingtons Disease Therapeutics Consumption (2014-2019)
      • 4.5 Japan Huntingtons Disease Therapeutics Consumption (2014-2019)

      5 Global Huntingtons Disease Therapeutics Production, Revenue, Price Trend by Type

      • 5.1 Global Huntingtons Disease Therapeutics Production Market Share by Type (2014-2019)
      • 5.2 Global Huntingtons Disease Therapeutics Revenue Market Share by Type (2014-2019)
      • 5.3 Global Huntingtons Disease Therapeutics Price by Type (2014-2019)
      • 5.4 Global Huntingtons Disease Therapeutics Production Growth by Type (2014-2019)

      6 Global Huntingtons Disease Therapeutics Market Analysis by Applications

      • 6.1 Global Huntingtons Disease Therapeutics Consumption Market Share by Application (2014-2019)
      • 6.2 Global Huntingtons Disease Therapeutics Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Huntingtons Disease Therapeutics Business

      • 7.1 Auspex Pharmaceuticals
        • 7.1.1 Auspex Pharmaceuticals Huntingtons Disease Therapeutics Production Sites and Area Served
        • 7.1.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification
        • 7.1.3 Auspex Pharmaceuticals Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Alnylam Pharmaceuticals
        • 7.2.1 Alnylam Pharmaceuticals Huntingtons Disease Therapeutics Production Sites and Area Served
        • 7.2.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification
        • 7.2.3 Alnylam Pharmaceuticals Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Intellect Neurosciences Incorporation
        • 7.3.1 Intellect Neurosciences Incorporation Huntingtons Disease Therapeutics Production Sites and Area Served
        • 7.3.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification
        • 7.3.3 Intellect Neurosciences Incorporation Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 H. Lundbeck
        • 7.4.1 H. Lundbeck Huntingtons Disease Therapeutics Production Sites and Area Served
        • 7.4.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification
        • 7.4.3 H. Lundbeck Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Prana Biotechnology Limited
        • 7.5.1 Prana Biotechnology Limited Huntingtons Disease Therapeutics Production Sites and Area Served
        • 7.5.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification
        • 7.5.3 Prana Biotechnology Limited Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Raptor Pharmaceuticals
        • 7.6.1 Raptor Pharmaceuticals Huntingtons Disease Therapeutics Production Sites and Area Served
        • 7.6.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification
        • 7.6.3 Raptor Pharmaceuticals Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Sangamo Biosciences
        • 7.7.1 Sangamo Biosciences Huntingtons Disease Therapeutics Production Sites and Area Served
        • 7.7.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification
        • 7.7.3 Sangamo Biosciences Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Teva Pharmaceutical Industries
        • 7.8.1 Teva Pharmaceutical Industries Huntingtons Disease Therapeutics Production Sites and Area Served
        • 7.8.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification
        • 7.8.3 Teva Pharmaceutical Industries Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Trophos SA
        • 7.9.1 Trophos SA Huntingtons Disease Therapeutics Production Sites and Area Served
        • 7.9.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification
        • 7.9.3 Trophos SA Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Valeant Pharmaceuticals International
        • 7.10.1 Valeant Pharmaceuticals International Huntingtons Disease Therapeutics Production Sites and Area Served
        • 7.10.2 Huntingtons Disease Therapeutics Product Introduction, Application and Specification
        • 7.10.3 Valeant Pharmaceuticals International Huntingtons Disease Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Vertex Pharmaceuticals
      • 7.12 Roche

      8 Huntingtons Disease Therapeutics Manufacturing Cost Analysis

      • 8.1 Huntingtons Disease Therapeutics Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Huntingtons Disease Therapeutics
      • 8.4 Huntingtons Disease Therapeutics Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Huntingtons Disease Therapeutics Distributors List
      • 9.3 Huntingtons Disease Therapeutics Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Huntingtons Disease Therapeutics Market Forecast

      • 11.1 Global Huntingtons Disease Therapeutics Production, Revenue Forecast
        • 11.1.1 Global Huntingtons Disease Therapeutics Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Huntingtons Disease Therapeutics Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Huntingtons Disease Therapeutics Price and Trend Forecast (2019-2025)
      • 11.2 Global Huntingtons Disease Therapeutics Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Huntingtons Disease Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Huntingtons Disease Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Huntingtons Disease Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Huntingtons Disease Therapeutics Production, Revenue Forecast (2019-2025)
      • 11.3 Global Huntingtons Disease Therapeutics Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Huntingtons Disease Therapeutics Consumption Forecast (2019-2025)
        • 11.3.2 Europe Huntingtons Disease Therapeutics Consumption Forecast (2019-2025)
        • 11.3.3 China Huntingtons Disease Therapeutics Consumption Forecast (2019-2025)
        • 11.3.4 Japan Huntingtons Disease Therapeutics Consumption Forecast (2019-2025)
      • 11.4 Global Huntingtons Disease Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Huntingtons Disease Therapeutics Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Huntington's disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington's disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington's disease.

        The global Huntingtons Disease Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Huntingtons Disease Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Huntingtons Disease Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Auspex Pharmaceuticals
        Alnylam Pharmaceuticals
        Intellect Neurosciences Incorporation
        H. Lundbeck
        Prana Biotechnology Limited
        Raptor Pharmaceuticals
        Sangamo Biosciences
        Teva Pharmaceutical Industries
        Trophos SA
        Valeant Pharmaceuticals International
        Vertex Pharmaceuticals
        Roche

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Antidopaminergics
        Anticonvulsants
        Antipsychotics
        Antidepressants

        Segment by Application
        Hosptial
        Clinic
        Research

        Buy now